Allogeneic marrow grafting for treatment of aplastic anemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000628:therapy*; D001792:Blood Platelets; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006087:Graft vs Host Reaction / Q000187:drug effects; D006650:Histocompatibility Testing; D006801:Humans; D007962:Leukocytes; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011830:Radiation Effects; D012730:Sex Chromosomes; D014181:Transplantation Immunology / Q000528:radiation effects; D014184:Transplantation, Homologous
D005665:Furosemide; D003520:Cyclophosphamide; D008727:Methotrexate